icosapent Capsules 0.5 g, 1 g
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #7363
One of China's major pharmaceutical enterprises with over five decades of operating history in Rx drug R&D and manufacturing. Portfolio spans injectables, oral solids, and APIs across oncology, cardiovascular, and anti-infective therapy areas. Holds domestic GMP certification with export presence in Asia and select international markets.
Manufacturer usually replies in 64 days